Managing Principal Anita Chawla Discusses Clinical Utility in the Context of Reimbursement Decisions

Event:Next Generation DX Summit – Commercialization of Molecular Diagnostics
Date:August 21, 2013
Host:Cambridge Healthtech Institute
Location:Washington, D.C.

Dr. Chawla presents "Next Generation Sequencing vs. Individual Assays - Implications for Demonstrating Clinical Utility in the Context of Reimbursement Decisions," in which she provides a framework for valuing clinical information over time and for evaluating evidence-based strategies. 

Associated Experts & Staff